INS and metabolic syndrome: These encompass a spectrum of factors, including the sympathoexcitatory effects of insulin, its modulation of sex hormone metabolism, the intricate entanglement of insulin in the insulin-like growth factor pathway, its involvement in signaling transduction cascades, and its consequential connections to dyslipidemia.